You will now be redirected to the GD3 website
Ingenio Diagnostics is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3SERVICES
Ingenio is pleased to offer Next Generation Sequencing services for those in need of high-throughput sequencing and large-scale functional screening. Our team is prepared to assist in customized project design and supports research from the bench to downstream analysis to reporting and deliverable components. Our current in-house sequencing capabilities include Illumina sequencing.
Additionally, we offer a variety of clinical panel testing, including:
- Pharmacogenomics (PGx) testing
- Genetic disorder carrier screening
- Hereditary cancer panels
- Cystic fibrosis testing
